• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性未分化/去分化皮肤黑色素瘤——组织学、免疫组织化学和分子特征的综述,重点是预后和治疗。

Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.

机构信息

Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Department of Pathology, University Emergency Hospital, 050098 Bucharest, Romania.

出版信息

Int J Mol Sci. 2023 Jun 10;24(12):9985. doi: 10.3390/ijms24129985.

DOI:10.3390/ijms24129985
PMID:37373134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10298704/
Abstract

Diagnosing cutaneous melanoma is usually straightforward based on these malignancies' histopathological and immunohistochemical features. Nevertheless, melanomas can imitate various other neoplasms, sometimes lacking the expression of conventional melanocytic markers and expressing non-melanocytic ones. Furthermore, divergent differentiation is more often encountered in metastatic melanomas and is still poorly described in primary cutaneous melanomas, and little is known about these patients' prognosis and therapeutic approach. Therefore, we reviewed the literature on undifferentiated/dedifferentiated cutaneous melanomas, and we discuss the histological, immunohistochemical, and molecular profiles of undifferentiated/dedifferentiated cutaneous melanomas to understand these peculiar lesions better and improve their diagnostic algorithm. In addition to this, we also discuss how different genetic mutations may influence prognosis and become potential therapeutic targets.

摘要

诊断皮肤黑色素瘤通常基于这些恶性肿瘤的组织病理学和免疫组织化学特征。然而,黑色素瘤可能模仿各种其他肿瘤,有时缺乏常规黑色素细胞标志物的表达,而表达非黑色素细胞标志物。此外,在转移性黑色素瘤中更常遇到分化趋异,在原发性皮肤黑色素瘤中仍描述甚少,关于这些患者的预后和治疗方法知之甚少。因此,我们复习了关于未分化/去分化皮肤黑色素瘤的文献,并讨论了未分化/去分化皮肤黑色素瘤的组织学、免疫组织化学和分子特征,以更好地了解这些特殊病变并改进其诊断算法。此外,我们还讨论了不同的遗传突变如何影响预后并成为潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bcc/10298704/f50065661548/ijms-24-09985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bcc/10298704/f50065661548/ijms-24-09985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bcc/10298704/f50065661548/ijms-24-09985-g001.jpg

相似文献

1
Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.原发性未分化/去分化皮肤黑色素瘤——组织学、免疫组织化学和分子特征的综述,重点是预后和治疗。
Int J Mol Sci. 2023 Jun 10;24(12):9985. doi: 10.3390/ijms24129985.
2
PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer.PRAME 更新:在皮肤癌中的诊断、预后和治疗作用。
Int J Mol Sci. 2024 Jan 27;25(3):1582. doi: 10.3390/ijms25031582.
3
Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.去分化黑色素瘤:形态表型特征、遗传重编程及临床意义。
Cancer Treat Rev. 2020 Aug;88:102060. doi: 10.1016/j.ctrv.2020.102060. Epub 2020 Jun 23.
4
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.伴有分化标志物完全缺失的转移性恶性黑色素瘤(未分化/去分化黑色素瘤):14例患者分析,强调表型可塑性及分子检测作为替代诊断标志物的价值
Am J Surg Pathol. 2016 Feb;40(2):181-91. doi: 10.1097/PAS.0000000000000527.
5
Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.环氧化酶-2(COX-2):区分早期皮肤黑色素瘤与良性皮肤黑素细胞肿瘤的首个免疫组化标志物。
Melanoma Res. 2007 Jun;17(3):139-45. doi: 10.1097/CMR.0b013e3280dec6ac.
6
Atypical Spitz Tumors: A Diagnostic Challenge.非典型斯皮茨瘤:一项诊断挑战。
Arch Pathol Lab Med. 2015 Oct;139(10):1263-70. doi: 10.5858/arpa.2015-0207-RA.
7
Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.皮肤黑素细胞病变的分子细胞遗传学——诊断、预后和治疗方面。
Histopathology. 2010 Jan;56(1):121-32. doi: 10.1111/j.1365-2559.2009.03452.x.
8
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Spitz样黑素细胞肿瘤中的基因组畸变及其对诊断、预后和治疗的意义。
Pathology. 2016 Feb;48(2):113-31. doi: 10.1016/j.pathol.2015.12.007. Epub 2016 Jan 18.
9
Pediatric melanomas and the atypical spitzoid melanocytic neoplasms.儿科黑色素瘤和非典型 Spitz 样黑素细胞肿瘤。
Am J Surg. 2012 Jun;203(6):761-7. doi: 10.1016/j.amjsurg.2011.04.008. Epub 2011 Dec 16.
10
PRAME Expression Is a Useful Tool in the Diagnosis of Primary and Metastatic Dedifferentiated and Undifferentiated Melanoma.PRAME 表达在原发性和转移性去分化及未分化黑色素瘤的诊断中是一种有用的工具。
Am J Surg Pathol. 2023 Dec 1;47(12):1390-1397. doi: 10.1097/PAS.0000000000002125. Epub 2023 Sep 19.

引用本文的文献

1
Primary Cutaneous Rhabdomyosarcomatous Melanomas-A Report of Two Cases and Literature Review.原发性皮肤横纹肌肉瘤样黑色素瘤——两例报告及文献复习
Diagnostics (Basel). 2025 May 28;15(11):1357. doi: 10.3390/diagnostics15111357.
2
Immunohistochemical investigation of the transcription factor PROX1 emphasizing on neuroendocrine neoplasms.转录因子PROX1的免疫组织化学研究,重点关注神经内分泌肿瘤。
Med Mol Morphol. 2025 Apr 15. doi: 10.1007/s00795-025-00437-z.
3
A Unique Case of High-Grade Dedifferentiated Melanoma Without a Known Primary Site.

本文引用的文献

1
Cutaneous Malignant Melanoma With Rhabdomyosarcomatous Dedifferentiation: an Immunohistological and Molecular Case Study With Literature Review.皮肤恶性黑色素瘤伴横纹肌样去分化:免疫组织化学和分子病例研究及文献复习。
Am J Dermatopathol. 2023 Jul 1;45(7):470-474. doi: 10.1097/DAD.0000000000002451. Epub 2023 May 2.
2
Dedifferentiated and undifferentiated melanomas: a practical approach to a challenging diagnosis.去分化和未分化黑色素瘤:具有挑战性诊断的实用方法。
Hum Pathol. 2023 Oct;140:22-31. doi: 10.1016/j.humpath.2023.03.014. Epub 2023 Mar 30.
3
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.
一例罕见的无已知原发部位的高级别去分化黑色素瘤病例。
Cureus. 2024 Aug 15;16(8):e66951. doi: 10.7759/cureus.66951. eCollection 2024 Aug.
4
Squamous Cell Carcinoma In Situ-The Importance of Early Diagnosis in Bowen Disease, Vulvar Intraepithelial Neoplasia, Penile Intraepithelial Neoplasia, and Erythroplasia of Queyrat.原位鳞状细胞癌——鲍温病、外阴上皮内瘤变、阴茎上皮内瘤变及凯腊增殖性红斑早期诊断的重要性
Diagnostics (Basel). 2024 Aug 16;14(16):1799. doi: 10.3390/diagnostics14161799.
5
Metastatic Nodular Melanoma with Angiosarcomatous Transdifferentiation-A Case Report and Review of the Literature.伴有血管肉瘤样转分化的转移性结节性黑色素瘤——1例报告并文献复习
Diagnostics (Basel). 2024 Jun 21;14(13):1323. doi: 10.3390/diagnostics14131323.
6
The Prognostic Value of Proliferative Activity in Cutaneous Melanoma: A Pilot Study Evaluating the Mitotic Rate and Ki67 Index to Predict Patient Outcomes.皮肤黑色素瘤增殖活性的预后价值:一项评估有丝分裂率和Ki67指数以预测患者预后的初步研究。
Biomedicines. 2024 Jun 13;12(6):1318. doi: 10.3390/biomedicines12061318.
7
Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management.皮肤黑色素瘤:多因素发病机制、免疫组织化学及早期检测和管理新兴生物标志物的综述。
Int J Mol Sci. 2023 Nov 1;24(21):15881. doi: 10.3390/ijms242115881.
8
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment.探索黑色素瘤细胞与肿瘤微环境之间复杂且多方面的相互作用。
Int J Mol Sci. 2023 Sep 21;24(18):14403. doi: 10.3390/ijms241814403.
NAPORAFENIB 联合曲美替尼治疗 - 突变型黑色素瘤的初步疗效证据:一项 Ib 期、开放标签研究扩展臂的结果。
J Clin Oncol. 2023 May 10;41(14):2651-2660. doi: 10.1200/JCO.22.02018. Epub 2023 Mar 22.
4
Age-related next-generation sequencing mutational analysis in 1196 melanomas.1196例黑色素瘤的年龄相关下一代测序突变分析
J Surg Oncol. 2023 Jun;127(7):1187-1195. doi: 10.1002/jso.27239. Epub 2023 Mar 20.
5
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance.黑色素瘤细胞的机械表型可塑性:治疗交叉耐药性的一个新出现的驱动因素。
Oncogenesis. 2023 Feb 11;12(1):7. doi: 10.1038/s41389-023-00452-8.
6
Characterisation and outcome of RAC1 mutated melanoma.RAC1 突变型黑色素瘤的特征和结局。
Eur J Cancer. 2023 Apr;183:1-10. doi: 10.1016/j.ejca.2023.01.009. Epub 2023 Jan 18.
7
Partially Dedifferentiated Primitive Malignant Melanoma with Pseudo-Angiomatous Features: A Case Report with Review of the Literature.具有假血管瘤样特征的部分去分化原始恶性黑色素瘤:一例报告并文献复习
Diagnostics (Basel). 2023 Jan 29;13(3):495. doi: 10.3390/diagnostics13030495.
8
Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.原发性肢端黑色素瘤中遗传异常和肿瘤免疫微环境的预后价值。
J Transl Med. 2023 Feb 4;21(1):78. doi: 10.1186/s12967-022-03856-z.
9
Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.SATB2在原发性皮肤肉瘤样肿瘤中的表达:一个潜在的诊断陷阱。
Pathology. 2023 Apr;55(3):350-354. doi: 10.1016/j.pathol.2022.10.011. Epub 2023 Jan 10.
10
p53 Family in Resistance to Targeted Therapy of Melanoma.p53 家族在抵抗黑色素瘤的靶向治疗中的作用。
Int J Mol Sci. 2022 Dec 21;24(1):65. doi: 10.3390/ijms24010065.